Gonzales, Nathalie E.
HRN: 26-83-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/14/2025
03/21/2025
IV
170mg
Q6h
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes